Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:19 pm Purchase | 13D | Tenaya Therapeutics, Inc. TNYA | COLUMN GROUP III LP | 13,599,275 17.700% | 2,229,001 (+19.60%) | View |
| 2024-02-09 5:22 pm Sale | 13G | Revolution Medicines, Inc. RVMD | COLUMN GROUP III LP | 46 0.000% | -3,347,153 (-100.00%) | View |
| 2023-02-21 5:26 pm Purchase | 13D | Tenaya Therapeutics, Inc. TNYA | COLUMN GROUP III LP | 11,370,274 17.800% | 1,754,890 (+18.25%) | View |
| 2023-02-13 4:23 pm Unchanged | 13G | Revolution Medicines, Inc. RVMD | COLUMN GROUP III LP | 3,347,199 3.800% | 0 (Unchanged) | View |
| 2022-12-01 4:13 pm Purchase | 13D | Tenaya Therapeutics, Inc. TNYA | COLUMN GROUP III LP | 9,615,384 15.000% | 215,094 (+2.29%) | View |
| 2022-02-11 4:36 pm Purchase | 13G | Tenaya Therapeutics, Inc. TNYA | COLUMN GROUP III LP | 9,400,290 22.800% | 9,400,290 (New Position) | View |
| 2022-02-11 4:23 pm Sale | 13G | Revolution Medicines, Inc. RVMD | COLUMN GROUP III LP | 3,347,199 4.500% | -233,007 (-6.51%) | View |
| 2021-02-12 6:25 pm Purchase | 13G | Revolution Medicines, Inc. RVMD | COLUMN GROUP III LP | 3,580,206 4.900% | 3,580,206 (New Position) | View |